Excipients, the inactive ingredients in pharmaceutical formulations, play a crucial role in ensuring the safety, efficacy, and stability of drugs. Proper storage conditions are essential to maintain the quality and integrity of these materials througho…
This chart shows the drugs with the most patents in Hungary. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in Hungary are: Juluca Cab…
Which pharmaceutical drugs have the most drug patents in Hungary? Read Post »
Introduction In the world of pharmaceuticals, excipients play a crucial role in the formulation and delivery of drugs. These inactive ingredients, while not providing any therapeutic effects themselves, are essential in ensuring the stability, bioavail…
Excipient Functionality: Breaking Down the Basics Read Post »
The Importance of Excipient Compatibility in Drug Development In the world of pharmaceutical formulation development, ensuring the compatibility between the […]
Source
Selecting the right excipients is a critical step in pharmaceutical formulation development. Excipients play a vital role in ensuring the […]
Source
How to Choose the Best Excipient for Your Formulation Read Post »
In the ever-evolving pharmaceutical landscape, savvy businesses are constantly on the lookout for untapped markets and lucrative opportunities. One area that has garnered significant attention is the realm of low-competition generic drugs. These are of…
Uncovering Lucrative Low-Competition Generic Drug Opportunities Read Post »
Annual Drug Patent Expirations for RINVOQ+LQ Rinvoq Lq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. The generic ingredient in RINVOQ LQ is upadacitinib. One supplier is listed for this compound. Additional…
Annual Drug Patent Expirations for JAKAFI Jakafi is a drug marketed by Incyte Corp and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Drug patent litigation for JA…
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from three suppliers. There are twenty-nine patents protecting this drug and two Paragraph IV challenges. XIFAXAN drug pri…
New patent expiration for Salix Pharms drug XIFAXAN Read Post »
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in two NDAs. It is available from one supplier. There are thirty-three patents protecting this drug. Drug patent litigation for RINVOQ. This drug has one hund…
Get new actionable insights and updates from BiotechBlog
